USABILITY AND PATIENT ACCEPTANCE OF PREFILLED OR REUSABLE INSULIN PENS

An analysis of patient acceptance and safety of a prefilled insulin injection device.

This article summarizes and interprets the findings of Carter and colleagues in this issue of Journal of Diabetes Science and Technology, a study of the real world use of a prefilled insulin pen device. In this observational study, people with type 1 and type 2 diabetes rated their experience with the SoloSTAR pen device after 6-10 weeks of use. Data on patient satisfaction, product technical c...

An evaluation of prefilled insulin pens: a focus on the Next Generation FlexPen®

Insulin pen delivery systems are preferred by patients over the traditional vial and syringe method for insulin delivery because they are simple and easy to use, improve confidence in dosing insulin, and have less interference with activities and improved discretion with use. Insulin manufacturers have made numerous improvements to their first marketed pen devices and are now introducing their ...

Perceptions of Usability and Design for Prefilled Insulin Delivery Devices for Patients With Type 2 Diabetes

United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pens.

The uptake of insulin pen use has been slow in the United States, despite their advantages over the vial/ syringe. We present results of a United States subset of 150 patients with type 1/type 2 diabetes, who were enrolled in an open-label study, that assessed usability, pen features, and patient preferences for four prefilled insulin pens: SoloSTAR, FlexPen, Lilly disposable pen, and a prototy...

Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience

PURPOSE This multicenter, randomized, crossover study compared preference, ease of use, acceptability, satisfaction, and safety of repeated subcutaneous (SC) self-administrations with prefilled pens and prefilled syringes delivering methotrexate (MTX), in patients with rheumatoid arthritis (RA). PATIENTS AND METHODS The study (ClinicalTrials.gov number NCT01793259) enrolled 120 patients requi...